» Articles » PMID: 36936437

Development of Alternative Herbals Remedy for Gastric Cancer Based on Transcriptomic Analysis of Immune Infiltration and Ferroptosis

Overview
Journal Front Genet
Date 2023 Mar 20
PMID 36936437
Authors
Affiliations
Soon will be listed here.
Abstract

Screening out potential herbal medicines and herbal ingredients for the treatment of gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis. Gene expression profiles of gastric tumour tissues and normal tissue samples were obtained from the GEO database and the samples were analysed for immune cell infiltration condition and differential expressed genes of ferroptosis. Key genes were screened by protein-protein interaction (PPI) and enrichment analysis, and molecular docking was used to predict and preliminary validate potential herbal and traditional Chinese medicine components for gastric cancer based on the key genes. Finally, RT-QPCR was used to validate the prediction results. Immune cell infiltration analysis revealed high levels of infiltration of activated CD4 memory T cells, monocytes, M0 macrophages in gastric tumor tissues, while plasma cells and resting mast cells had higher levels of infiltration in the paraneoplastic tissues. Differential gene expression analysis identified 1,012 upregulated genes and 880 downregulated genes, of which 84 immune related differentially expressed genes such as CTSB, PGF and PLAU and 10 ferroptosis-related differentially expressed genes such as HSF1, NOX4 and NF2 were highly expressed in gastric cancer tissues. The results of enrichment analysis showed that they mainly involve 343 biological processes such as extracellular matrix organization and extracellular structural organization; 37 cellular components such as complexes of collagen trimer and basement membrane; 35 molecular functions such as signal receptor activator activity and receptor ligand activity; 19 regulatory pathways such as cytokine-cytokine receptor interactions and retinol metabolism. Finally, two key genes, TLR4 and KRAS, were selected and 12 herbal medicines such as and 27 herbal ingredients such as resveratrol, salvianolic acid b were predicted on the basis of key genes. Molecular docking results showed that KRAS binds tightly to coumarin and magnolol, while TLR4 can bind tightly to resveratrol, curcumin, salvianolic acid b, shikonin. Subsequently, the effect of resveratrol and magnolol was experimentally verified. Herbal medicines such as and herbal ingredients such as resveratrol, curcumin, salvianolic acid b may provide research directions and alternative therapeutic approaches for immunomodulation of TME and ferroptosis of tumour cells in gastric cancer.

Citing Articles

Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics.

Peng L, Hu X, Liu Z, Liu W, Huang Q, Wen Y Front Pharmacol. 2024; 15:1473939.

PMID: 39386035 PMC: 11461341. DOI: 10.3389/fphar.2024.1473939.


Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer.

Mazurek M, Szewc M, Sitarz M, Dudzinska E, Sitarz R Cancers (Basel). 2024; 16(18).

PMID: 39335135 PMC: 11430327. DOI: 10.3390/cancers16183163.


Potential Roles and Mechanisms of Curcumin and its Derivatives in the Regulation of Ferroptosis.

Zhang Y, Yu C, Peng C, Peng F Int J Biol Sci. 2024; 20(12):4838-4852.

PMID: 39309443 PMC: 11414380. DOI: 10.7150/ijbs.90798.


Ferroptosis and its current progress in gastric cancer.

Yue Z, Yuan Y, Zhou Q, Sheng J, Xin L Front Cell Dev Biol. 2024; 12:1289335.

PMID: 38481532 PMC: 10933004. DOI: 10.3389/fcell.2024.1289335.


Amplifying Curcumin's Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment.

Kabagwira J, Fuller R, Vallejos P, Sugiono C, Andrianarijaona V, Chism J Onco Targets Ther. 2024; 17:63-78.

PMID: 38313386 PMC: 10838088. DOI: 10.2147/OTT.S448024.

References
1.
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C . Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019; 12(1):34. PMC: 6441206. DOI: 10.1186/s13045-019-0720-y. View

2.
Coutzac C, Pernot S, Chaput N, Zaanan A . Immunotherapy in advanced gastric cancer, is it the future?. Crit Rev Oncol Hematol. 2019; 133:25-32. DOI: 10.1016/j.critrevonc.2018.10.007. View

3.
Pietrantonio F, Miceli R, Raimondi A, Kim Y, Kang W, Langley R . Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. J Clin Oncol. 2019; 37(35):3392-3400. DOI: 10.1200/JCO.19.01124. View

4.
Boutin A, Liao W, Wang M, Hwang S, Karpinets T, Cheung H . Oncogenic drives invasion and maintains metastases in colorectal cancer. Genes Dev. 2017; 31(4):370-382. PMC: 5358757. DOI: 10.1101/gad.293449.116. View

5.
Abozeid M, Rosato A, Sommaggio R . Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development. Biomed Res Int. 2017; 2017:5791262. PMC: 5525095. DOI: 10.1155/2017/5791262. View